文献速递病毒性肝炎

冈比亚孕妇乙肝母婴传播残余风险与照护级联缺口:INFANT-B研究

Residual Risk of Hepatitis B Virus Mother-to-Child Transmission and Gaps in Care Cascades Among Pregnant Women in the Gambia: The INFANT-B Study.
PubMed 文献 · J Infect Dis · 2025-01-01

该多中心非随机干预研究在冈比亚城乡产前门诊为连续孕妇提供乙肝筛查,HBsAg阳性母亲及婴儿随访至产后6-9个月。9697名孕妇中HBsAg阳性率4.6%,可追踪活产中216名婴儿完成检测,母婴传播率2.8%。研究识别出新生儿乙肝疫苗出生剂次未接种、风险分层采血拒采及产后未链接照护等重大缺口。

要点

  • 孕妇HBsAg阳性率4.6%(95%CI 4.2-5.1),完成检测婴儿的HBV母婴传播率为2.8%。
  • 64%新生儿未接种乙肝疫苗出生剂次,62%HBsAg阳性孕妇产后未链接照护。
  • 仅<2%孕妇符合2017 EASL或2024 WHO指南的产后治疗条件。

核心结论

  • 冈比亚HBV母婴传播残余风险超过消除绝对目标,亟需改善围产期和产后HBV照护级联的策略。

研究设计与样本

  • 多中心非随机干预研究,2019-2022年在冈比亚城乡产前门诊纳入连续孕妇,提供HBV检测并前瞻性随访HBsAg阳性母亲及婴儿至产后6-9个月。

主要发现

  • 9697/9708(99.9%)孕妇接受HBV筛查,449例HBsAg阳性,阳性率4.6%(95%CI 4.2-5.1)。
  • 428例可追踪活产中216例(49.6%)婴儿完成HBV检测,6例HBsAg阳性,母婴传播率2.8%(95%CI 1.1%-6.2%)。
  • 64%新生儿未接种乙肝疫苗出生剂次,25%HBsAg阳性孕妇拒绝为风险分层采血,62%产后未链接照护。
  • 根据2017 EASL和2024 WHO指南,<2%女性符合产后治疗条件。

关键数值与推荐

  • HBV母婴传播率定义为HBsAg阳性婴儿比例,本研究中为2.8%(95%CI 1.1%-6.2%)。
  • HBsAg阳性率4.6%(95%CI 4.2-5.1),基于9697名孕妇中449例阳性。

临床怎么用

  • 在冈比亚产前门诊实施HBV筛查可被孕妇高度接受(99.9%),但需关注新生儿出生剂次疫苗接种、风险分层采血及产后链接照护的缺口。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elimination of hepatitis B virus (HBV) is not achievable without prevention of mother-to-child transmission (MTCT). In its 2024 guidelines, the World Health Organization identified major research gaps on HBV MTCT in Africa. Following the implementation of antenatal HBV screening in The Gambia, we estimated the rate of HBV MTCT and the peripartum care cascade among pregnant women. METHODS: This multicenter nonrandomized interventional study was conducted in urban and rural antenatal clinics in The Gambia. Following mass and individual sensitization, consecutive pregnant women were offered HBV testing and blood collection for further retrospective HBV MTCT risk assessment including HBV DNA viral load and HBeAg serology. HBsAg-positive mothers and their babies were prospectively followed up to 6 to 9 months postpartum. The primary end point was the rate of HBV MTCT defined by the proportion of HBsAg-positive babies. RESULTS: Between 2019 and 2022, 9697 of 9708 (99.9%) pregnant women accepted HBV screening; 449 of 9697 tested positive (hepatitis B surface antigen [HBsAg] prevalence, 4.6%; 95% CI, 4.2-5.1). Among 428 traceable live births, 216 (49.6%) babies were successfully tested for HBV; 6 of 216 were HBsAg positive, giving a 2.8% rate of MTCT (95% CI, 1.1%-6.2%). Major gaps in HBV prevention and care services were identified: 64% of newborns did not receive HBV birth dose vaccine, 25% of HBsAg-positive pregnant women refused to give blood for further risk stratification, and 62% were not linked to care after delivery. A small proportion (<2%) of women were eligible for postpartum treatment according to the 2017 guidelines of the European Association for the Study of the Liver and the 2024 guidelines of the World Health Organization. CONCLUSIONS: In The Gambia, the residual risk of HBV MTCT exceeds the elimination absolute target. Strategies to improve the peripartum and postpartum HBV care cascade are urgently needed.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ndow G, Bangura R, Vo-Quang E, et al. Residual Risk of Hepatitis B Virus Mother-to-Child Transmission and Gaps in Care Cascades Among Pregnant Women in the Gambia: The INFANT-B Study. J Infect Dis. 2025. PMID: 40304086. doi:10.1093/infdis/jiaf214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。